Clinical Trial Update: Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating peri-operative immune checkpoint inhibition with cryoablation in women with triple-negative breast cancer; study status is act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING